IM Cannabis Corp. (IMCC) stock
Close on Nov 11, 2026Market cap $3.39MP/E –Yield –
IM Cannabis Corp. grew revenue 1.3% to C$54.73M over fiscal 2025. Free cash flow was C$4.70M. At the latest close the market valued the company at C$4.78M.
Key statistics
Valuation at the latest close; fundamentals over fiscal 2025, balances at Jun 30, 2026
Valuation
- Market cap
- C$4.78M
- P/E ratio
- –
- Price to sales
- 0.09
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- 98.36%
Fundamentals
- Revenue
- C$54.73M
- Net income
- -C$11.32M
- Free cash flow
- C$4.70M
Trading
- Previous close
- $0.61
- Open
- $0.64
- Day's range
- $0.56 – $0.64
- Volume
- 30,811
- Average volume (20 days)
- 56,158
- Beta (5 years)
- 1.35
- RSI (14 days)
- 28.5
- Volatility (1 year)
- 194.2%
- Relative volume
- 0.02×
- WACC
- 11.7%
Market cap history
Month-end market cap since 2020, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | IMCC | S&P 500 | Difference | IMCC per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -63.6% | -2.4% | −61.2 pts | ||
| 3 months | -85.5% | -1.2% | −84.4 pts | ||
| Year to date | -98.6% | +12.3% | −110.9 pts | ||
| 1 year | -98.7% | +12.4% | −111.1 pts | ||
| 3 years | -99.3% | +78.8% | −178.1 pts | -80.9% | +21.4% |
| 5 years | -100.0% | +75.2% | −175.2 pts | -83.5% | +11.9% |
Eight years at a glance
Fiscal years 2018 to 2025, CAD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases IM Cannabis filed with the SEC as exhibits to Form 8-K or 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
About IM Cannabis
Medicinal Chemicals & Botanical Products
The company operates in the medical cannabis industry, engaging in the cultivation, processing, marketing, and distribution of cannabis products. Its offerings include bulk cannabis, packaged dried cannabis, and other cannabis-derived products, along with medical herb distribution. Operating through pharmacy entities such as Oranim and Rayarok Pharm, as well as holding interests in entities like Focus and Adjupharm, the business serves retail customers, pharmacies, and medical patients seeking cannabis products and related healthcare supplies.
Company profile, executives and historyIM Cannabis stock: common questions
What is IM Cannabis's stock price?
IMCC closed at $0.57 on Nov 11, 2026, down 6.05% on the day.
What is IM Cannabis's market cap?
IM Cannabis was worth $3.39M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
How much revenue does IM Cannabis make?
IM Cannabis reported revenue of C$54.73M for fiscal 2025, up 1.3% from a year earlier.
Does IM Cannabis pay a dividend?
No. IM Cannabis has not paid a cash dividend over the last twelve months.
How has IMCC stock performed over the past year?
Including dividends, IMCC returned -98.7% over the past year, against +12.4% for the S&P 500.
Who are IM Cannabis's competitors?
Companies most similar to IM Cannabis by business, industry and size include CGC, CWLXF, CRON, ACB, LEEEF.
See a number that looks wrong?